Has Robert Iadevaio, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,254 in general payments to Robert Iadevaio, MD across 396 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Iadevaio, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Iadevaio, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Iadevaio, MD

Pain Medicine · Rockville Centre, NYNPI 1285613760

Payments from drug & device makers

$20,254in general payments, 2019–2025

Across 396 payments — averaging $51.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Relievant Medsystems, Inc.$8K
Vertos Medical, Inc.$3K
Abbott$1K
Boston Scientific$1K
Medtronic$1K
AbbVie$1K
plus $5K from 37 others

What the payments were for

Consulting fees$2,50012%
Speaking & faculty fees$6,58032%
Travel & lodging$6393%
Food & beverage$10,53552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Relievant Medsystems, Inc.	26	$7,870
Vertos Medical, Inc.	2	$2,500
Abbott	26	$1,459
Boston Scientific	46	$1,399
Medtronic(2 entities)	28	$1,218
AbbVie(2 entities)	51	$1,035
Collegium Pharmaceutical, Inc.	51	$931
Nevro Corp.	40	$775
Scilex Pharmaceuticals Inc.	33	$586
Redhill Biopharma Inc.	12	$329
Intrinsic Therapeutics	3	$270
Globus Medical	3	$159
Valinor Pharma, LLC	8	$154
Forte Bio-pharma LLC	3	$149
Biodelivery Sciences International, Inc.	7	$140
Baxter Healthcare	1	$124
Kowa Pharmaceuticals America, Inc.	6	$107
Painteq LLC	2	$92
Pfizer	6	$90
Avanos Medical	3	$86
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$80
Stimwave Technologies Incorporated	2	$70
Johnson & Johnson	4	$69
Virtus Pharmaceuticals LLC	3	$56
Averitas Pharma Inc.	2	$52
Bioventus LLC	2	$41
Daiichi Sankyo Inc.	2	$41
DJO, LLC	1	$37
Almatica Pharma LLC	2	$36
MML US, Inc.	1	$35
Ultragenyx Pharmaceutical Inc.	2	$32
Saluda Medical Americas, Inc.	2	$32
Ferring Pharmaceuticals Inc.	1	$24
Zyla Life Sciences, Inc.	1	$23
Si-bone, Inc.	1	$23
Pacira Therapeutics, Inc.	1	$20
Shionogi Inc	1	$20
GRT US Holding, Inc.	1	$16
Arbor Pharmaceuticals, Inc.	1	$16
Hikma Pharmaceuticals USA	1	$15
Sentynl Therapeutics, Inc.	1	$15
Masimo Corporation	1	$14
MDD US Operations, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Intracept$28,255
mild Device Kit$2,500
Proclaim Family of SCS IPGs$578
Senza$264
Senza Spinal Cord Stimulation System$256
GENERAL PAIN MANAGEMENT$230
KYPHON EXPRESS II KYPHOPAK TRAY$175
Proclaim IPG$167
OSTEOCOOL RF ABLATION SYSTEM$163
MYSTIM$152
INTELLIS ADAPTIVESTIM$142
PROCLAIM$129
ACTIFUSE$124
Barricaid Annular Closure Device$120
MOVANTIK$120
INTELLIS$101

How this compares

$20,254 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$322,691

Medicare patients

656

Services billed

4,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	12	$7,064
Pregabalin	35	$1,797
Gabapentin	113	$1,582
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	57	$771
Oxycodone Hcl	32	$739
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	62	$646
Diclofenac Sodium	25	$437
Cyclobenzaprine Hcl	34	$339
Celecoxib	26	$320
Tramadol Hcl	69	$264
Meloxicam	29	$201
Tizanidine Hcl	38	$199
Duloxetine Hcl	20	$169
Methylprednisolone	19	$95
Methocarbamol	11	$91

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rockville Centre

Gary SchwartzBrooklyn$756K
Amitabh GulatiNew York$627K
William CaldwellStony Brook$550K
Brian DurkinPort Jefferson$459K
Grace FordeNew Hyde Park$398K
David SpinnerNew York$391K
John MarkmanRochester$300K
Naum ShaparinBronx$178K
Ashraf HenryAmherst$168K
Kenneth ChapmanStaten Island$160K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →